Humana Inc. $HUM Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Humana Inc. (NYSE:HUM) by 6.5% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 230,907 shares of the insurance provider’s stock after buying an additional 14,179 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Humana were worth $56,452,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Parkside Financial Bank & Trust grew its holdings in shares of Humana by 36.2% during the second quarter. Parkside Financial Bank & Trust now owns 564 shares of the insurance provider’s stock valued at $138,000 after purchasing an additional 150 shares during the last quarter. Aviva PLC boosted its position in Humana by 6.7% during the 2nd quarter. Aviva PLC now owns 89,753 shares of the insurance provider’s stock valued at $21,943,000 after purchasing an additional 5,657 shares during the period. Penserra Capital Management LLC grew its stake in Humana by 13.0% during the 2nd quarter. Penserra Capital Management LLC now owns 662 shares of the insurance provider’s stock worth $161,000 after buying an additional 76 shares during the last quarter. Pekin Hardy Strauss Inc. increased its position in Humana by 3.7% in the second quarter. Pekin Hardy Strauss Inc. now owns 34,587 shares of the insurance provider’s stock worth $8,456,000 after buying an additional 1,246 shares during the period. Finally, Savant Capital LLC lifted its stake in Humana by 22.1% in the second quarter. Savant Capital LLC now owns 13,485 shares of the insurance provider’s stock valued at $3,297,000 after buying an additional 2,438 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of NYSE HUM opened at $251.46 on Monday. The business’s 50-day moving average price is $278.04 and its two-hundred day moving average price is $258.86. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The company has a market capitalization of $30.24 billion, a P/E ratio of 19.30, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. During the same period in the previous year, the company earned $4.16 EPS. The company’s revenue for the quarter was up 11.1% on a year-over-year basis. Analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio is 33.18%.

Analyst Ratings Changes

A number of research firms recently weighed in on HUM. Wolfe Research increased their price objective on shares of Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a report on Monday, October 6th. Evercore ISI initiated coverage on Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price target on the stock. Guggenheim reiterated a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Truist Financial set a $300.00 target price on Humana in a research report on Tuesday, October 14th. Finally, Sanford C. Bernstein lifted their target price on Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $299.22.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.